Contact information
Gesa Gnegel
Research Pharmacist
Dr Gesa Gnegel joined the Medicine Quality Research Group as a research pharmacist in 2024. She works on the development of a dashboard as a guidance tool for medicines regulatory authorities to select portable screening technologies for the detection of substandard and falsified medicines in post-market surveillance.
Gesa studied pharmacy at the University of Freiburg, Germany and at the University of San José, Costa Rica. During her PhD at the University of Tübingen, Germany, she assessed screening devices for the detection of substandard and falsified medicines and taught pharmacy students in literature research and information management. She also worked as a coordinator of a network of pharmacists in African countries and India who implemented the screening technology GPHF-Minilab in their facilities (Difäm-EPN Minilab Network).
Recent publications
-
Verification of the active pharmaceutical ingredient in tablets using a low-cost near-infrared spectrometer
Gabel J. et al, (2023), Talanta Open, 8, 100270 - 100270
-
Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab
Gnegel G. et al, (2022), Scientific Reports, 12
-
Quality of oxytocin and misoprostol in health facilities of Rwanda
Bizimana T. et al, (2021), PLOS ONE, 16, e0245054 - e0245054
-
Identification of Falsified Chloroquine Tablets in Africa at the Time of the COVID-19 Pandemic.
Gnegel G. et al, (2020), The American journal of tropical medicine and hygiene, 103, 73 - 76